ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Pediatric rheumatology"

  • Abstract Number: 1782 • ACR Convergence 2024

    DOCK2 Mutations and Hyper-Inflammatory Syndromes

    Randy Cron, Mingce Zhang and Prescott Atkinson, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Cytokine storm syndromes (CSS) are frequently fatal hyper-inflammatory complications of a variety of oncologic, rheumatic, and infectious diseases. Many patients with CSS possess heterozygous…
  • Abstract Number: 2173 • ACR Convergence 2024

    Hope and Health in Adolescents with Chronic Musculoskeletal Pain

    Irene Chern1, Mackenzie McGill2, Nellie P Butler2 and Sabrina Gmuca2, 1St. Christopher's Hospital for Children, Philadelphia, PA, 2Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Hope, the capability to derive pathways to desired goals and motivate oneself via agency thinking plays a protective role in pediatric health contributing to…
  • Abstract Number: 2198 • ACR Convergence 2024

    Severe and Long-Term Outcomes of COVID-19 Infection and Vaccine Hesitancy and Adverse Events in Children with Pediatric Rheumatic Diseases: Insights from a COVID-19 Global Rheumatology Alliance Caregiver Survey

    Jonathan Hausmann1, Kevin Kennedy2, Ethan Knapp3, Nadine Lalonde4, jOhn Wallace5, Richard Howard6, Marcela Alvarez7, Mariana Fabi8, Lorena Franco9, Rebecca Grainger10, Jean Liew11, Pedro M Machado12, Zachary Wallace13, Jinoos Yazdany14 and Emily Sirotich15, and COVID-19 Global Rheumatology Alliance, 1Division of Immunology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 2McMaster University, Hamilton, ON, Canada, 3University of Connecticut School of Medicine, Farmington, CT, 4COVID-19 Global Rheumatology Alliance, London, ON, Canada, 5Covid 19 Global Rheumatology Alliance Patient Board, EDINBURGH, United Kingdom, 6Spondylitis Association of America, Encino, CA, 7CHIDRENS HOSPITAL DR. RICARDO GUTIERREZ ARGENTINA, Buenos Aires, Argentina, 8Argentine Society of Rheumatology, La Plata, Argentina, 9Argentine Society of Rheumatology, Cordoba, Argentina, 10University of Otago, Wellington, New Zealand, 11Boston University, Boston, MA, 12Department of Neuromuscular Diseases and Centre for Rheumatology, University College London, London, United Kingdom, 13Massachusetts General Hospital, Newton, MA, 14UCSF, San Francisco, CA, 15Yale University, Vaughan, ON, Canada

    Background/Purpose: Children have the lowest COVID-19 vaccination rates of any age group. In adults with rheumatic diseases, barriers to vaccination include the perceived lack of…
  • Abstract Number: 2569 • ACR Convergence 2024

    A Novel Hyperferritinemia Screen to Aid Differentiation of Hyperinflammatory Disorders

    Hallie Carol1, Adam Mayer2, Jemy Varghese3, Zachary Martinez4, Caroline Diorio4, Paul Tsoukas5, Kate Kernan6 and Scott Canna7, 1Children's Hospital of Philadelphia, Philadelphia, 2University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, PA, 3Division of Pediatric Rheumatology, The Children’s Hospital of Philadelphia, Philadelphia, PA, 4Division of Pediatric Oncology, The Children’s Hospital of Philadelphia, Philadelphia, PA, 5Hospital for Sick Children/University of Toronto, Toronto, ON, Canada, 6Department of Critical Care Medicine, University of Pittsburgh School of Medicine, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, 7Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: High ferritin is an important and sensitive biomarker for the diverse and deadly group of cytokine storm syndromes grouped together under the term hemophagocytic…
  • Abstract Number: PP13 • ACR Convergence 2024

    Bridging the Gap from Pediatric to Adult Rheumatology Care

    Natasha Trehan, University of Ottawa, Take a Pain Check Foundation, Markham, ON, Canada

    Background/Purpose: When I was 13, life took an unexpected turn with a diagnosis of Juvenile Idiopathic Arthritis (JIA). Overnight, my world transformed into a cycle…
  • Abstract Number: 0387 • ACR Convergence 2024

    Absolute Agreement and Inter-rater Reliability of a Web-based Standardized Scoring Tool for Magnetic Resonance Images from Children with Chronic Nonbacterial Osteomyelitis (CNO) Amongst Radiologists

    Farzana Nuruzzaman1, T. Shawn Sato2, Jennifer Stimec3, Ramesh S. Iyer4, Andrew Carbert5, Joel Paschke5, Lauren Potts6, Xiaoyue Zhang7, Walter Maksymowych8, Polly Ferguson9 and Yongdong (Dan) Zhao10, and CARRA CRMO Workgroup, 1Stony Brook Children's Hospital, Stony Brook, NY, 2University of Iowa, Iowa City, 3Hospital for Sick Children, Toronto, ON, Canada, 4Seattle Children's Hospital, Seattle, WA, 5CARE Arthritis, Edmonton, AB, Canada, 6Artist, Long Beach, CA, 7Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 8University of Alberta, Edmonton, AB, Canada, 9University of Iowa Carver College of Medicine, Iowa City, IA, 10University of Washington, Redmond, WA

    Background/Purpose: The web-based ChRonic nonbacterial Osteomyelitis Magnetic Resonance Imaging Scoring (CROMRIS) portal was developed to assess specific features of bone and soft tissue inflammation in…
  • Abstract Number: 0412 • ACR Convergence 2024

    Impact of Approval of Biologic DMARDs on JIA Outcomes in a Single Center

    Anna Sutton1, Erin Balay-Dustrude1, Beth A Mueller1 and Susan Shenoi2, 1University of Washington, Seattle, WA, 2Seattle Children's Hospital and Research Center, Mercer Island, WA, WA

    Background/Purpose: In clinical trials, biologic disease-modifying antirheumatic drugs (bDMARDs) for juvenile idiopathic arthritis (JIA) have demonstrated good efficacy. However, less is known about the impact…
  • Abstract Number: 1258 • ACR Convergence 2024

    Investigating Factors Associated with Gaps in Care in Adolescents and Young Adults with Systemic Lupus

    Tamar Rubinstein1, Avni Dave2, Terrence Calistro3, Kimberly Rapoza3, Joyce Hui-Yuen4, Emily Masi5, Shari Salzhauer Berkowitz3, Zanab Mian6 and Kathleen Kenney-Riley7, 1Albert Einstein College of Medicine, White Plains, NY, 2Albert Einstein College of Medicine, Bronx, NY, 3Mercy University, Dobbs Ferry, NY, 4North Shore LIJ Health System, Great Neck, NY, 5Cohen Children's Medical Center, Floral Park, NY, 6Cohen Children's Medical Center, Lake Success, NY, 7Albert Einstein College of Medicine, Port Chester, NY

    Background/Purpose: Adolescents and young adults (AYA) with systemic lupus (SLE) are at an especially high risk for disengagement in care, a possible cause of the…
  • Abstract Number: 1275 • ACR Convergence 2024

    Implementing Integrated Mental Health Care in a Juvenile Myositis Clinic: A One-Year Review

    Luana Flores Pereira1, Louise Boulard2, Kayla M. Baker3, Audrey Bell-Peter4, Vanessa Carbone3, Brian Feldman5, Jayne MacMahon6, Valerio Maniscalco7, Jo-Anne Marcuz8, Tanya Slater4, Kristi Whitney4, Y. Ingrid Goh3 and Andrea Knight9, 1Neurosciences and Mental Health Program, SickKids Research Institute, Toronto, ON, Canada, 2Neurosciences and Mental Health Program, SickKids Research Institute; The Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 3Division of Rheumatology, The Hospital for Sick Children; Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada, 4Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 5Division of Rheumatology, The Hospital for Sick Children; Departments of Pediatrics and Medicine, Faculty of Medicine; The Institute for Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, 6Division of Rheumatology, The Hospital for Sick Children; Department of Pediatrics, Temerty Faculty of Medicine, University of Toronto; Child Health Evaluative Sciences, SickKids Research Institute, Toronto, ON, Canada, 7Rheumatology Unit, ERN-ReCONNET Center, Meyer Children Hospital IRCCS; Department of Pediatrics, Santo Stefano Hospital, Florence, Italy, 8Division on Rheumatology, The Hospital for Sick Children; Department of Rehabilitation Services, The Hospital for Sick Children, Toronto, ON, Canada, 9Division of Rheumatology, The Hospital for Sick Children; Neurosciences and Mental Health, SickKids Research Institute; Department of Paediatrics, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Juvenile myositis (JM) patients experience a high burden of emotional distress, yet mental health (MH) care is not typically integrated into standard clinical practices.…
  • Abstract Number: 1739 • ACR Convergence 2024

    Adult and Pediatric Rheumatology Fellow Education on Temporomandibular Joint (TMJ) Arthritis in Patients with Juvenile Idiopathic Arthritis

    Sarah Bayefsky1, Meghan Ryan2, Nancy Pan3, Tova Ronis4, Marinka Twilt5, Melissa Lerman6 and CARRA TMJ Workgroup7, 1University of Pennsylvania/Children's Hospital of Philadelphia, PHILADELPHIA, PA, 2Unity Point - Blank Children's Hospital, Booneville, IA, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 4Children's National Hospital, Washington, DC, 5Alberta Children's Hospital, Calgary, AB, Canada, 6Children's Hospital of Philadelphia, Philadelphia, PA, 7CARRA, Washington, DC

    Background/Purpose: Arthritis of the temporomandibular joint, or TMJ arthritis, is an underrecognized manifestation of juvenile idiopathic arthritis (JIA). The absence of prompt treatment may lead…
  • Abstract Number: 1792 • ACR Convergence 2024

    CD14+ Monocytes Demonstrate Subclinical Erythrocyte Uptake in Childhood Onset Systemic Lupus Erythematosus

    Lauren Robinson1, Preetha Balasubramanian2, Zurong Wan2, Juan Rodriguez Alcazar2, Marina Lima Silva Santos2, Lynnette Walters3, Jeanine Baisch2, Karen Onel4, Tracey Wright5, Virginia Pascual6 and Simone Caielli2, 1Hospital for Special Surgery, New York, NY, 2Weill Cornell Medicine, New York, NY, 3Scottish Rite Hospital for Children, Allen, TX, 4HSS, New York, NY, 5UT Southwestern, Plano, TX, 6Weill Cornell Medical College, New York, NY

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is a disease characterized by the presence of auto-antibodies, immune complex deposition, and a robust type I interferon (IFN) signature.…
  • Abstract Number: 2176 • ACR Convergence 2024

    Applying Similarity Network Fusion to Identify Patient Clusters for People with Systemic Inflammatory Disease

    Nicholas C Chan1, Anika Rueppell2, Daniela Dominguez3, Tom Appleton4, Michelle Batthish5, Roberta A Berard6, Tania Cellucci5, Erkan Demirkaya7, Michelle Diebold6, Liane Heale8, Peter Kannu9, Deborah Levy10, Jonathan Park11, Jean-Philippe Proulx-Gauthier12, Angela Punnett10, Johannes Roth13, Rayfel Schneider14, Lynn Spiegel15, Rae Yeung16, Jason An1, Anjali Jain3, Madeline Couse10, Dilan Dissanayake10, Ronald Laxer2, Lauren Erdman10 and Linda Hiraki10, 1University of Toronto, Toronto, ON, Canada, 2SickKids, Toronto, ON, Canada, 3The Hospital for Sick Children, Toronto, Canada, 4The University of Western Ontario, London, ON, Canada, 5McMaster Children's Hospital, Hamilton, ON, Canada, 6London Health Sciences Centre, London, ON, Canada, 7Victoria Hospital & Children's Hospital, Toronto, ON, Canada, 8McMaster University, Oakville, ON, Canada, 9University of Alberta, Edmonton, AB, Canada, 10The Hospital for Sick Children, Toronto, ON, Canada, 11London Health Sciences Centre Victoria Hospital, Lodon, Canada, 12l'Université Laval, Quebec City, QC, Canada, 13Cantonal Hospital Luzern and Children's Hospital of Central Switzerland, Luzern, Switzerland, 14The Hospital for Sick Children, Toronto, Ontario, Canada, Toronto, ON, Canada, 15University of Toronto/Hospital for Sick Children, Toronto, ON, Canada, 16The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Systemic inflammatory diseases (SIDs) are characterized by non-infectious multisystem inflammation. Genetic panels only diagnose 25% of suspected SID patients, due to the clinical and…
  • Abstract Number: 2200 • ACR Convergence 2024

    Whole Blood Transcriptome Profiling in Juvenile Systemic Sclerosis Patients Reveals Active Immune Upregulation and Enhanced Fibrotic Signature

    Rania Elbakri1, Amanda Robinson2, Anwesha Sanyal1 and Kathryn Torok3, 1University of Pittsburgh, pittsburgh, PA, 2University of Utah Health, Salt Lake City, UT, 3Division of Rheumatology, Scleroderma Center, Department of Pediatrics, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, PA

    Background/Purpose: Juvenile systemic sclerosis (jSSc) is a rare chronic autoimmune disorder characterized by skin thickening and multisystem organ involvement, leading to significant morbidity. The pathogenesis…
  • Abstract Number: 2570 • ACR Convergence 2024

    Comparison of the Clinical Features and Biomarker Profiles of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Systemic Juvenile Idiopathic Arthritis- Associated Lung Disease (SJIA-LD) Cohort to CARRA Registry SJIA Patients Without Lung Disease

    Esraa Eloseily1, Autumn Clark1, Min-Lee Chang2, Mary Ellen Riordan3, Alan Russell4, Marc Natter5, Scott Canna6, Sherry Thornton7, Yukiko Kimura8 and grant schulert1, and CARRA FROST Investigators and the CARRA Registry SJIA-LD Cohort Investigators, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Computational Health Informatics Program, Boston Children’s Hospital, Boston, MA, 3Hackensack University Medical Center, Westwood, NJ, 4Duke Clinical Research Institute, Durham, NC, 5Boston Children's Hospital, Boston, MA, 6Children's Hospital of Philadelphia, Philadelphia, PA, 7Cincinnati Children's Hospital, Cincinnati, 8Hackensack Meridian School of Medicine, New York, NY

    Background/Purpose: Systemic juvenile idiopathic arthritis (SJIA) associated lung disease (SJIA-LD) is an emerging life-threatening disease with urgent unmet knowledge gaps. This study compares the clinical…
  • Abstract Number: 0389 • ACR Convergence 2024

    Histopathological Features of Liver Tissue Biopsies in SJIA Patients with and Without Clinical Macrophage Activation Syndrome

    Esraa Eloseily1, Lara Berklite2, Jennifer Picarsic1, grant schulert1, Rachel Sheridan1 and Alexei Grom1, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Cincinnati Children's Hospital Medical Center, Cincinnti, OH

    Background/Purpose: Systemic Juvenile Idiopathic Arthritis (SJIA) can present with or without Macrophage Activation Syndrome (MAS), a severe, potentially life-threatening complication. Liver tissue injury is commonly…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 52
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology